Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 21 | 2022 | 2113 | 1.690 |
Why?
|
Radiology Department, Hospital | 16 | 2014 | 406 | 1.100 |
Why?
|
Tomography, X-Ray Computed | 78 | 2015 | 20570 | 0.990 |
Why?
|
Radiology Information Systems | 9 | 2011 | 529 | 0.930 |
Why?
|
Diagnostic Imaging | 21 | 2022 | 3530 | 0.900 |
Why?
|
Contrast Media | 30 | 2007 | 5311 | 0.710 |
Why?
|
Hospital Communication Systems | 2 | 2014 | 48 | 0.610 |
Why?
|
Radiation Protection | 2 | 2012 | 424 | 0.590 |
Why?
|
Nobel Prize | 1 | 2016 | 48 | 0.520 |
Why?
|
Humanism | 1 | 2016 | 86 | 0.500 |
Why?
|
Reimbursement Mechanisms | 1 | 2020 | 667 | 0.460 |
Why?
|
Radiation Injuries | 2 | 2012 | 1189 | 0.460 |
Why?
|
Unnecessary Procedures | 2 | 2014 | 415 | 0.460 |
Why?
|
Academic Medical Centers | 8 | 2012 | 2759 | 0.450 |
Why?
|
Social Responsibility | 1 | 2016 | 386 | 0.430 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 3 | 2013 | 1222 | 0.410 |
Why?
|
Liver | 20 | 1999 | 7529 | 0.400 |
Why?
|
Radiation Monitoring | 1 | 2012 | 103 | 0.390 |
Why?
|
Liposomes | 14 | 1995 | 784 | 0.370 |
Why?
|
Biopsy, Needle | 6 | 1998 | 1626 | 0.360 |
Why?
|
Decision Support Systems, Clinical | 3 | 2014 | 1175 | 0.360 |
Why?
|
Neurosurgery | 1 | 2016 | 679 | 0.330 |
Why?
|
Triiodobenzoic Acids | 5 | 1995 | 123 | 0.320 |
Why?
|
Interinstitutional Relations | 1 | 2010 | 236 | 0.310 |
Why?
|
Safety Management | 2 | 2012 | 760 | 0.310 |
Why?
|
Industry | 1 | 2010 | 364 | 0.290 |
Why?
|
Diagnosis, Computer-Assisted | 3 | 2019 | 710 | 0.290 |
Why?
|
Radiography, Abdominal | 6 | 2001 | 534 | 0.260 |
Why?
|
Abdominal Neoplasms | 5 | 1998 | 287 | 0.260 |
Why?
|
Wounds and Injuries | 5 | 2020 | 2491 | 0.260 |
Why?
|
Diatrizoate | 9 | 1994 | 81 | 0.260 |
Why?
|
Liver Neoplasms | 11 | 2002 | 4320 | 0.260 |
Why?
|
Cardiology | 1 | 2016 | 1656 | 0.240 |
Why?
|
Conflict of Interest | 1 | 2010 | 554 | 0.240 |
Why?
|
Fractures, Bone | 3 | 2021 | 2046 | 0.240 |
Why?
|
Magnetic Resonance Imaging | 20 | 2016 | 36426 | 0.240 |
Why?
|
Planning Techniques | 2 | 2020 | 82 | 0.230 |
Why?
|
Radiation Dosage | 1 | 2012 | 1958 | 0.230 |
Why?
|
Radiography | 10 | 2010 | 6965 | 0.220 |
Why?
|
History, 21st Century | 3 | 2016 | 1567 | 0.220 |
Why?
|
Hospitals, Teaching | 4 | 2010 | 1156 | 0.220 |
Why?
|
Solitary Pulmonary Nodule | 2 | 1998 | 278 | 0.210 |
Why?
|
Organizational Objectives | 3 | 2020 | 426 | 0.210 |
Why?
|
Awards and Prizes | 1 | 2007 | 360 | 0.210 |
Why?
|
Quality Improvement | 3 | 2015 | 3801 | 0.210 |
Why?
|
Pyridoxal Phosphate | 1 | 2002 | 125 | 0.200 |
Why?
|
User-Computer Interface | 4 | 2011 | 1400 | 0.200 |
Why?
|
Visual Perception | 4 | 2022 | 1387 | 0.200 |
Why?
|
Radiographic Image Enhancement | 6 | 1997 | 876 | 0.200 |
Why?
|
History, 20th Century | 4 | 2016 | 2767 | 0.200 |
Why?
|
Radiology, Interventional | 4 | 2014 | 476 | 0.200 |
Why?
|
Shoulder Fractures | 2 | 2021 | 93 | 0.190 |
Why?
|
Referral and Consultation | 7 | 2015 | 3600 | 0.190 |
Why?
|
Artificial Intelligence | 3 | 2022 | 2578 | 0.190 |
Why?
|
Observer Variation | 9 | 2003 | 2606 | 0.190 |
Why?
|
Edetic Acid | 1 | 2002 | 280 | 0.190 |
Why?
|
Total Quality Management | 3 | 2004 | 265 | 0.190 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2003 | 219 | 0.190 |
Why?
|
Biomedical Research | 2 | 2016 | 3429 | 0.180 |
Why?
|
Efficiency, Organizational | 4 | 2010 | 695 | 0.180 |
Why?
|
Skull Fractures | 1 | 2022 | 202 | 0.180 |
Why?
|
Facial Injuries | 1 | 2022 | 190 | 0.180 |
Why?
|
Arm Injuries | 1 | 2021 | 156 | 0.170 |
Why?
|
Decision Making, Organizational | 1 | 2020 | 136 | 0.160 |
Why?
|
Humans | 143 | 2022 | 761504 | 0.160 |
Why?
|
United States | 19 | 2020 | 72334 | 0.160 |
Why?
|
Computer Systems | 1 | 2000 | 470 | 0.160 |
Why?
|
ROC Curve | 11 | 2002 | 3579 | 0.150 |
Why?
|
Health Care Reform | 2 | 2020 | 1247 | 0.150 |
Why?
|
Spleen | 5 | 1995 | 2295 | 0.150 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2001 | 385 | 0.150 |
Why?
|
Diatrizoate Meglumine | 5 | 1997 | 79 | 0.150 |
Why?
|
Models, Organizational | 2 | 2020 | 546 | 0.150 |
Why?
|
Boston | 9 | 2016 | 9326 | 0.140 |
Why?
|
Medical Order Entry Systems | 2 | 2013 | 521 | 0.140 |
Why?
|
Hospital-Physician Joint Ventures | 1 | 1996 | 30 | 0.140 |
Why?
|
Insurance Claim Review | 1 | 2001 | 741 | 0.140 |
Why?
|
Organometallic Compounds | 4 | 1999 | 647 | 0.140 |
Why?
|
Hungary | 1 | 2016 | 82 | 0.130 |
Why?
|
Pentetic Acid | 3 | 1991 | 209 | 0.130 |
Why?
|
Time and Motion Studies | 2 | 2010 | 143 | 0.130 |
Why?
|
Terminology as Topic | 1 | 2003 | 1530 | 0.130 |
Why?
|
Utilization Review | 2 | 2014 | 382 | 0.130 |
Why?
|
Medical Informatics | 3 | 2013 | 733 | 0.130 |
Why?
|
Meglumine | 3 | 1991 | 144 | 0.130 |
Why?
|
Iodipamide | 2 | 1985 | 7 | 0.130 |
Why?
|
Medical Records | 3 | 2004 | 1408 | 0.120 |
Why?
|
Radiography, Interventional | 4 | 2003 | 1121 | 0.120 |
Why?
|
Algorithms | 3 | 2014 | 14031 | 0.120 |
Why?
|
Vertigo | 3 | 1992 | 202 | 0.120 |
Why?
|
Quality Assurance, Health Care | 2 | 2004 | 2169 | 0.120 |
Why?
|
Managed Care Programs | 2 | 1996 | 940 | 0.110 |
Why?
|
Research | 1 | 2002 | 1982 | 0.110 |
Why?
|
Physician's Role | 1 | 2020 | 917 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 1994 | 1374 | 0.110 |
Why?
|
Ear, Inner | 3 | 1993 | 425 | 0.110 |
Why?
|
Hospitals, Urban | 2 | 2012 | 500 | 0.110 |
Why?
|
Patient Participation | 1 | 2002 | 1444 | 0.110 |
Why?
|
Hodgkin Disease | 2 | 1994 | 1378 | 0.110 |
Why?
|
Libraries | 1 | 1992 | 21 | 0.110 |
Why?
|
X-Ray Film | 1 | 1992 | 31 | 0.100 |
Why?
|
Resilience, Psychological | 1 | 2020 | 788 | 0.100 |
Why?
|
Internship and Residency | 4 | 2022 | 5880 | 0.100 |
Why?
|
Central Nervous System Diseases | 2 | 1999 | 520 | 0.100 |
Why?
|
Adrenal Glands | 4 | 1993 | 552 | 0.100 |
Why?
|
Gadolinium | 4 | 1999 | 960 | 0.100 |
Why?
|
Lumbar Vertebrae | 2 | 2014 | 1879 | 0.090 |
Why?
|
Iodine Radioisotopes | 5 | 1991 | 1031 | 0.090 |
Why?
|
Interprofessional Relations | 2 | 2011 | 990 | 0.090 |
Why?
|
Liver Diseases | 5 | 1999 | 1298 | 0.090 |
Why?
|
Marketing of Health Services | 1 | 1992 | 151 | 0.090 |
Why?
|
Labyrinthitis | 1 | 1991 | 32 | 0.090 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2013 | 173 | 0.090 |
Why?
|
Mediastinum | 4 | 1986 | 267 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2002 | 2298 | 0.090 |
Why?
|
Token Economy | 1 | 2010 | 17 | 0.090 |
Why?
|
Lung Diseases | 2 | 2000 | 1909 | 0.090 |
Why?
|
Psychophysics | 1 | 2011 | 292 | 0.090 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 495 | 0.090 |
Why?
|
Patient Selection | 1 | 2002 | 4244 | 0.090 |
Why?
|
Eye Movements | 1 | 2013 | 511 | 0.090 |
Why?
|
Iodobenzoates | 2 | 1987 | 10 | 0.080 |
Why?
|
Politics | 1 | 2016 | 815 | 0.080 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2014 | 942 | 0.080 |
Why?
|
Oxides | 3 | 1995 | 401 | 0.080 |
Why?
|
Fee-for-Service Plans | 1 | 2014 | 700 | 0.080 |
Why?
|
Image Enhancement | 3 | 1995 | 2885 | 0.080 |
Why?
|
Patient Care Planning | 1 | 1994 | 908 | 0.080 |
Why?
|
Computer Simulation | 2 | 2002 | 6240 | 0.080 |
Why?
|
Barium Sulfate | 3 | 1985 | 180 | 0.080 |
Why?
|
Adult | 55 | 2022 | 221177 | 0.080 |
Why?
|
Spinal Diseases | 1 | 2014 | 564 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 2 | 2013 | 4063 | 0.080 |
Why?
|
Information Systems | 1 | 2010 | 396 | 0.080 |
Why?
|
Radionuclide Imaging | 8 | 2013 | 1972 | 0.080 |
Why?
|
Size Perception | 1 | 1988 | 32 | 0.080 |
Why?
|
Mediastinal Neoplasms | 2 | 1984 | 401 | 0.080 |
Why?
|
Joint Diseases | 3 | 1982 | 459 | 0.080 |
Why?
|
Internet | 1 | 2000 | 3092 | 0.080 |
Why?
|
Tissue Distribution | 7 | 1995 | 2265 | 0.080 |
Why?
|
Middle Aged | 50 | 2022 | 220895 | 0.070 |
Why?
|
Dogs | 6 | 1995 | 3839 | 0.070 |
Why?
|
Motivation | 2 | 2010 | 2006 | 0.070 |
Why?
|
Pattern Recognition, Visual | 1 | 2013 | 820 | 0.070 |
Why?
|
Computer Communication Networks | 2 | 2000 | 293 | 0.070 |
Why?
|
Lymph Nodes | 2 | 2000 | 3466 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2013 | 1302 | 0.070 |
Why?
|
Health Care Costs | 1 | 2020 | 3242 | 0.070 |
Why?
|
Ultrasonography | 9 | 2000 | 5972 | 0.070 |
Why?
|
Male | 61 | 2022 | 360804 | 0.070 |
Why?
|
Labyrinthine Fluids | 1 | 1986 | 15 | 0.070 |
Why?
|
Female | 61 | 2022 | 392644 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2002 | 8002 | 0.070 |
Why?
|
Upper Extremity | 2 | 2021 | 657 | 0.070 |
Why?
|
Perilymph | 1 | 1986 | 50 | 0.070 |
Why?
|
Sarcoidosis | 1 | 1991 | 521 | 0.070 |
Why?
|
Cost Control | 3 | 1998 | 628 | 0.060 |
Why?
|
Hepatectomy | 1 | 1989 | 557 | 0.060 |
Why?
|
Lung | 5 | 2013 | 10000 | 0.060 |
Why?
|
Low Back Pain | 1 | 2014 | 984 | 0.060 |
Why?
|
Drug Carriers | 5 | 1995 | 706 | 0.060 |
Why?
|
Commerce | 1 | 2010 | 606 | 0.060 |
Why?
|
Diffusion of Innovation | 1 | 2010 | 728 | 0.060 |
Why?
|
Ascites | 1 | 1987 | 338 | 0.060 |
Why?
|
Fistula | 2 | 1986 | 212 | 0.060 |
Why?
|
Body Fluids | 2 | 1984 | 320 | 0.060 |
Why?
|
Employee Incentive Plans | 1 | 2004 | 15 | 0.060 |
Why?
|
Education, Medical | 2 | 2015 | 1725 | 0.060 |
Why?
|
Retrospective Studies | 18 | 2022 | 80636 | 0.060 |
Why?
|
Practice Management | 1 | 2004 | 37 | 0.060 |
Why?
|
Biliary Tract | 1 | 1985 | 135 | 0.060 |
Why?
|
Labyrinth Diseases | 1 | 1986 | 151 | 0.060 |
Why?
|
Ankle Joint | 2 | 1985 | 446 | 0.060 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2005 | 148 | 0.060 |
Why?
|
Deglutition | 2 | 1996 | 208 | 0.060 |
Why?
|
Osteomyelitis | 2 | 1988 | 407 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2019 | 4811 | 0.060 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2007 | 285 | 0.060 |
Why?
|
Compensation and Redress | 1 | 2004 | 66 | 0.060 |
Why?
|
Technology Assessment, Biomedical | 2 | 2003 | 307 | 0.060 |
Why?
|
Communication | 3 | 2011 | 3873 | 0.060 |
Why?
|
Shoulder Dislocation | 1 | 1985 | 129 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2014 | 2220 | 0.050 |
Why?
|
Relative Value Scales | 3 | 2014 | 84 | 0.050 |
Why?
|
Spinal Injuries | 1 | 2007 | 301 | 0.050 |
Why?
|
Medical Oncology | 1 | 2015 | 2321 | 0.050 |
Why?
|
Hearing Loss | 1 | 1991 | 783 | 0.050 |
Why?
|
Adrenal Gland Neoplasms | 5 | 1993 | 732 | 0.050 |
Why?
|
Soft Tissue Neoplasms | 3 | 1994 | 1159 | 0.050 |
Why?
|
Needles | 2 | 1998 | 451 | 0.050 |
Why?
|
Pelvis | 3 | 1984 | 732 | 0.050 |
Why?
|
Gases | 1 | 1984 | 204 | 0.050 |
Why?
|
Costs and Cost Analysis | 4 | 2000 | 1668 | 0.050 |
Why?
|
Gadolinium DTPA | 3 | 1991 | 823 | 0.050 |
Why?
|
Task Performance and Analysis | 2 | 2013 | 763 | 0.050 |
Why?
|
Aged | 40 | 2022 | 169289 | 0.050 |
Why?
|
Physician Incentive Plans | 1 | 2004 | 164 | 0.050 |
Why?
|
Biliary Tract Diseases | 2 | 1980 | 159 | 0.050 |
Why?
|
Drug Compounding | 4 | 1991 | 246 | 0.050 |
Why?
|
Anesthesia, General | 2 | 2007 | 1174 | 0.050 |
Why?
|
Models, Theoretical | 1 | 1994 | 3575 | 0.050 |
Why?
|
X-Ray Intensifying Screens | 2 | 2000 | 32 | 0.050 |
Why?
|
Esophagus | 2 | 1986 | 1033 | 0.050 |
Why?
|
Thoracic Vertebrae | 1 | 2007 | 597 | 0.050 |
Why?
|
Iron | 3 | 1995 | 1793 | 0.050 |
Why?
|
Aortic Rupture | 2 | 1983 | 319 | 0.050 |
Why?
|
Random Allocation | 2 | 2003 | 2395 | 0.050 |
Why?
|
Income Tax | 1 | 1982 | 24 | 0.050 |
Why?
|
Prostatic Neoplasms | 3 | 1997 | 11118 | 0.050 |
Why?
|
Joints | 2 | 1982 | 322 | 0.050 |
Why?
|
Iodides | 1 | 1981 | 40 | 0.050 |
Why?
|
Silver Compounds | 1 | 1981 | 23 | 0.050 |
Why?
|
Echo-Planar Imaging | 2 | 1996 | 663 | 0.050 |
Why?
|
Vocal Cords | 2 | 1996 | 522 | 0.050 |
Why?
|
False Negative Reactions | 2 | 1998 | 573 | 0.050 |
Why?
|
Biomedical Technology | 1 | 2003 | 211 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 3 | 1985 | 3763 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 8 | 1998 | 9000 | 0.040 |
Why?
|
Tomography | 2 | 1984 | 411 | 0.040 |
Why?
|
Lung Neoplasms | 5 | 2013 | 13380 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2014 | 7390 | 0.040 |
Why?
|
Peritoneal Neoplasms | 1 | 1987 | 711 | 0.040 |
Why?
|
Foot | 1 | 1984 | 575 | 0.040 |
Why?
|
Unconsciousness | 1 | 2002 | 250 | 0.040 |
Why?
|
Forms and Records Control | 2 | 2004 | 158 | 0.040 |
Why?
|
Shoulder Joint | 3 | 1985 | 742 | 0.040 |
Why?
|
Emergency Service, Hospital | 2 | 2021 | 7879 | 0.040 |
Why?
|
Cervical Vertebrae | 2 | 2002 | 980 | 0.040 |
Why?
|
Rats | 10 | 1995 | 23742 | 0.040 |
Why?
|
Neoplasm Staging | 5 | 1997 | 11121 | 0.040 |
Why?
|
Manganese | 1 | 2002 | 395 | 0.040 |
Why?
|
Zinostatin | 1 | 1978 | 7 | 0.040 |
Why?
|
Rectum | 1 | 1984 | 892 | 0.040 |
Why?
|
Digestive System | 1 | 1979 | 244 | 0.040 |
Why?
|
Cecal Diseases | 1 | 1978 | 49 | 0.040 |
Why?
|
Young Adult | 6 | 2022 | 59243 | 0.040 |
Why?
|
Faculty, Medical | 2 | 2001 | 1203 | 0.040 |
Why?
|
Pelvic Neoplasms | 2 | 1992 | 247 | 0.040 |
Why?
|
Evaluation Studies as Topic | 6 | 1995 | 1624 | 0.040 |
Why?
|
Enema | 1 | 1978 | 141 | 0.040 |
Why?
|
Intestines | 1 | 1987 | 1909 | 0.040 |
Why?
|
Shoulder | 1 | 1979 | 300 | 0.040 |
Why?
|
Intestinal Perforation | 2 | 1982 | 249 | 0.040 |
Why?
|
Quality Control | 1 | 2000 | 832 | 0.040 |
Why?
|
Color | 2 | 1995 | 299 | 0.040 |
Why?
|
Primary Health Care | 1 | 2014 | 4686 | 0.040 |
Why?
|
Adenocarcinoma | 4 | 1994 | 6346 | 0.040 |
Why?
|
Mammography | 3 | 1992 | 2430 | 0.030 |
Why?
|
Adolescent | 13 | 2021 | 88319 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2020 | 1045 | 0.030 |
Why?
|
Educational Measurement | 1 | 1984 | 1254 | 0.030 |
Why?
|
Perception | 1 | 2003 | 1197 | 0.030 |
Why?
|
Kidney Neoplasms | 5 | 1996 | 4249 | 0.030 |
Why?
|
Medicare | 1 | 2015 | 6770 | 0.030 |
Why?
|
Health Facility Merger | 1 | 1997 | 47 | 0.030 |
Why?
|
Choristoma | 1 | 1978 | 206 | 0.030 |
Why?
|
Documentation | 2 | 2011 | 897 | 0.030 |
Why?
|
Parathyroid Glands | 1 | 1978 | 518 | 0.030 |
Why?
|
Data Display | 2 | 1997 | 175 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 1987 | 2538 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2022 | 1039 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1516 | 0.030 |
Why?
|
Efficiency | 1 | 1998 | 476 | 0.030 |
Why?
|
Clinical Competence | 1 | 2011 | 4792 | 0.030 |
Why?
|
Probability | 2 | 2019 | 2477 | 0.030 |
Why?
|
Program Development | 2 | 2011 | 1297 | 0.030 |
Why?
|
Drug Combinations | 2 | 1991 | 2048 | 0.030 |
Why?
|
Angiomyolipoma | 1 | 1996 | 187 | 0.030 |
Why?
|
Carcinoma 256, Walker | 2 | 1985 | 38 | 0.030 |
Why?
|
Leadership | 1 | 2004 | 1385 | 0.030 |
Why?
|
Appointments and Schedules | 2 | 2004 | 443 | 0.030 |
Why?
|
Urologic Diseases | 1 | 1997 | 247 | 0.030 |
Why?
|
Chi-Square Distribution | 3 | 2011 | 3416 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1978 | 678 | 0.030 |
Why?
|
Pulmonary Fibrosis | 1 | 1978 | 505 | 0.030 |
Why?
|
Cholangiography | 3 | 1985 | 181 | 0.030 |
Why?
|
Attitude of Health Personnel | 2 | 2002 | 3889 | 0.030 |
Why?
|
Hospitalization | 1 | 2014 | 10723 | 0.030 |
Why?
|
Half-Life | 1 | 1995 | 651 | 0.030 |
Why?
|
Cicatrix | 1 | 2000 | 798 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15732 | 0.030 |
Why?
|
Logistic Models | 3 | 2014 | 13255 | 0.030 |
Why?
|
Artifacts | 2 | 2000 | 1911 | 0.030 |
Why?
|
Transillumination | 1 | 1992 | 20 | 0.030 |
Why?
|
Massachusetts | 3 | 2011 | 8830 | 0.030 |
Why?
|
Program Evaluation | 2 | 2011 | 2495 | 0.030 |
Why?
|
Kidney Diseases, Cystic | 1 | 1994 | 183 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 1999 | 809 | 0.030 |
Why?
|
Diagnosis, Differential | 8 | 1997 | 12974 | 0.030 |
Why?
|
Cysts | 1 | 1978 | 681 | 0.030 |
Why?
|
Predictive Value of Tests | 4 | 1998 | 15266 | 0.030 |
Why?
|
Technology, Radiologic | 3 | 1997 | 160 | 0.030 |
Why?
|
Models, Structural | 1 | 1992 | 340 | 0.030 |
Why?
|
Technetium | 3 | 1982 | 317 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 1978 | 2218 | 0.020 |
Why?
|
Adrenal Gland Diseases | 1 | 1993 | 141 | 0.020 |
Why?
|
Benchmarking | 1 | 1998 | 1045 | 0.020 |
Why?
|
Mononuclear Phagocyte System | 1 | 1991 | 54 | 0.020 |
Why?
|
Specialization | 1 | 1997 | 778 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2010 | 2850 | 0.020 |
Why?
|
Hearing Loss, Sudden | 1 | 1992 | 45 | 0.020 |
Why?
|
Punctures | 1 | 1993 | 366 | 0.020 |
Why?
|
Motion | 1 | 1995 | 779 | 0.020 |
Why?
|
Animals | 19 | 1995 | 168459 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 1995 | 2561 | 0.020 |
Why?
|
Aged, 80 and over | 7 | 2014 | 58976 | 0.020 |
Why?
|
Preoperative Care | 2 | 2005 | 2242 | 0.020 |
Why?
|
Rib Fractures | 2 | 1983 | 128 | 0.020 |
Why?
|
Cohort Studies | 3 | 2021 | 41487 | 0.020 |
Why?
|
Rabbits | 5 | 1987 | 4772 | 0.020 |
Why?
|
Sensitivity and Specificity | 6 | 1997 | 14666 | 0.020 |
Why?
|
Authorship | 1 | 1994 | 284 | 0.020 |
Why?
|
Prospective Studies | 9 | 2010 | 54425 | 0.020 |
Why?
|
Cardiac Imaging Techniques | 1 | 2013 | 267 | 0.020 |
Why?
|
Retroperitoneal Neoplasms | 1 | 1994 | 333 | 0.020 |
Why?
|
Blood Coagulation Tests | 1 | 1991 | 271 | 0.020 |
Why?
|
Methods | 2 | 1988 | 1067 | 0.020 |
Why?
|
Teaching | 1 | 1998 | 1170 | 0.020 |
Why?
|
Temporomandibular Joint Disorders | 2 | 1984 | 222 | 0.020 |
Why?
|
Systems Integration | 1 | 2012 | 426 | 0.020 |
Why?
|
Audiometry | 2 | 1992 | 253 | 0.020 |
Why?
|
Societies, Medical | 1 | 1982 | 3905 | 0.020 |
Why?
|
Speech Recognition Software | 1 | 2010 | 74 | 0.020 |
Why?
|
Ferrosoferric Oxide | 3 | 1995 | 348 | 0.020 |
Why?
|
Pleural Neoplasms | 2 | 1986 | 609 | 0.020 |
Why?
|
Breast Neoplasms | 4 | 1992 | 21012 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 1997 | 20098 | 0.020 |
Why?
|
Calcinosis | 1 | 1978 | 1469 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 1989 | 6935 | 0.020 |
Why?
|
Prostate | 1 | 1997 | 1770 | 0.020 |
Why?
|
Magnetite Nanoparticles | 3 | 1995 | 318 | 0.020 |
Why?
|
Time Factors | 7 | 1998 | 39967 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 2 | 1994 | 3164 | 0.020 |
Why?
|
Dextrans | 3 | 1995 | 574 | 0.020 |
Why?
|
Neurilemmoma | 1 | 1994 | 526 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3743 | 0.020 |
Why?
|
Nephrectomy | 1 | 1994 | 937 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 1997 | 2526 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12059 | 0.020 |
Why?
|
Medicine | 1 | 1997 | 942 | 0.020 |
Why?
|
Iohexol | 3 | 1997 | 204 | 0.020 |
Why?
|
Lethal Dose 50 | 2 | 1985 | 72 | 0.020 |
Why?
|
Mesothelioma | 2 | 1986 | 807 | 0.020 |
Why?
|
Endoscopy | 1 | 1997 | 1851 | 0.020 |
Why?
|
Abdomen | 1 | 1993 | 1128 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9610 | 0.020 |
Why?
|
Internal Medicine | 1 | 1994 | 1051 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 1995 | 10766 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2013 | 1985 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 1987 | 361 | 0.020 |
Why?
|
Hearing Loss, Sensorineural | 1 | 1993 | 781 | 0.020 |
Why?
|
Inpatients | 1 | 1998 | 2548 | 0.020 |
Why?
|
Anesthesia, Intravenous | 1 | 2007 | 128 | 0.020 |
Why?
|
Administration, Oral | 2 | 1985 | 4021 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22170 | 0.020 |
Why?
|
Forecasting | 1 | 2015 | 2928 | 0.020 |
Why?
|
Anesthesia, Inhalation | 1 | 2007 | 220 | 0.020 |
Why?
|
Biopsy | 1 | 1998 | 6766 | 0.020 |
Why?
|
Iothalamic Acid | 1 | 1985 | 17 | 0.020 |
Why?
|
Foot Deformities, Acquired | 1 | 1985 | 27 | 0.020 |
Why?
|
Hearing Disorders | 1 | 1986 | 126 | 0.020 |
Why?
|
Joint Loose Bodies | 1 | 1985 | 19 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1978 | 2223 | 0.020 |
Why?
|
Ointments | 1 | 1985 | 58 | 0.020 |
Why?
|
Temporomandibular Joint | 2 | 1984 | 201 | 0.020 |
Why?
|
Data Collection | 1 | 1994 | 3322 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5428 | 0.020 |
Why?
|
Permeability | 1 | 1987 | 723 | 0.010 |
Why?
|
Splenic Infarction | 1 | 1984 | 12 | 0.010 |
Why?
|
Economics, Medical | 1 | 1985 | 112 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2005 | 11460 | 0.010 |
Why?
|
Foot Deformities, Congenital | 1 | 1984 | 59 | 0.010 |
Why?
|
Cognition | 1 | 2022 | 6990 | 0.010 |
Why?
|
Drug Storage | 1 | 1984 | 52 | 0.010 |
Why?
|
Cholecystography | 2 | 1980 | 42 | 0.010 |
Why?
|
Tympanic Membrane | 1 | 1986 | 232 | 0.010 |
Why?
|
Abscess | 2 | 1985 | 606 | 0.010 |
Why?
|
Software | 1 | 1998 | 4434 | 0.010 |
Why?
|
Hyperplasia | 3 | 1986 | 1152 | 0.010 |
Why?
|
Pneumoperitoneum | 1 | 1984 | 46 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1995 | 8181 | 0.010 |
Why?
|
Liver Function Tests | 1 | 1985 | 523 | 0.010 |
Why?
|
Rats, Inbred Strains | 3 | 1990 | 2088 | 0.010 |
Why?
|
Feasibility Studies | 1 | 1994 | 5247 | 0.010 |
Why?
|
Pain | 2 | 1997 | 5073 | 0.010 |
Why?
|
Sternum | 1 | 1984 | 175 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 1985 | 3769 | 0.010 |
Why?
|
Research Design | 1 | 2019 | 6180 | 0.010 |
Why?
|
Tinnitus | 1 | 1986 | 196 | 0.010 |
Why?
|
Financial Management | 1 | 2004 | 160 | 0.010 |
Why?
|
Injections, Intravenous | 2 | 1999 | 1379 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1992 | 2691 | 0.010 |
Why?
|
Xeroradiography | 1 | 1982 | 6 | 0.010 |
Why?
|
Sodium Pertechnetate Tc 99m | 1 | 1982 | 54 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 1998 | 14605 | 0.010 |
Why?
|
Papio | 1 | 1984 | 669 | 0.010 |
Why?
|
Pericardium | 1 | 1986 | 675 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21353 | 0.010 |
Why?
|
Analysis of Variance | 2 | 2004 | 6228 | 0.010 |
Why?
|
Dysprosium | 1 | 1981 | 24 | 0.010 |
Why?
|
Starch | 1 | 1981 | 79 | 0.010 |
Why?
|
Muscles | 1 | 1986 | 1576 | 0.010 |
Why?
|
Cerium | 1 | 1981 | 9 | 0.010 |
Why?
|
Asbestos | 1 | 1983 | 251 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9646 | 0.010 |
Why?
|
Edema | 1 | 1985 | 766 | 0.010 |
Why?
|
Thymus Neoplasms | 1 | 1984 | 274 | 0.010 |
Why?
|
Microsurgery | 1 | 2007 | 795 | 0.010 |
Why?
|
Diagnostic Errors | 3 | 1986 | 1265 | 0.010 |
Why?
|
Teratoma | 1 | 1984 | 404 | 0.010 |
Why?
|
Tomography, X-Ray | 1 | 1980 | 60 | 0.010 |
Why?
|
Carcinoid Tumor | 1 | 1982 | 224 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 1991 | 1998 | 0.010 |
Why?
|
Cushing Syndrome | 1 | 1982 | 241 | 0.010 |
Why?
|
Silver | 1 | 1981 | 117 | 0.010 |
Why?
|
Lipids | 1 | 1991 | 3341 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 2007 | 942 | 0.010 |
Why?
|
Knee | 1 | 1982 | 279 | 0.010 |
Why?
|
Glasgow Coma Scale | 1 | 2002 | 580 | 0.010 |
Why?
|
Hydrarthrosis | 1 | 1979 | 6 | 0.010 |
Why?
|
Irritants | 1 | 1979 | 43 | 0.010 |
Why?
|
Radioisotopes | 1 | 1981 | 499 | 0.010 |
Why?
|
Chemistry | 1 | 1979 | 347 | 0.010 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 1979 | 49 | 0.010 |
Why?
|
Esophageal Perforation | 1 | 1979 | 65 | 0.010 |
Why?
|
Congenital Abnormalities | 1 | 1984 | 709 | 0.010 |
Why?
|
Genomics | 1 | 2015 | 5821 | 0.010 |
Why?
|
Stomach Volvulus | 1 | 1978 | 6 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7967 | 0.010 |
Why?
|
Inhalation | 1 | 1979 | 143 | 0.010 |
Why?
|
Hematoma | 1 | 1984 | 768 | 0.010 |
Why?
|
Fetal Diseases | 1 | 1984 | 913 | 0.010 |
Why?
|
Research Support as Topic | 1 | 2003 | 697 | 0.010 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 1978 | 117 | 0.010 |
Why?
|
Angiography | 2 | 1983 | 1595 | 0.010 |
Why?
|
Aorta, Thoracic | 2 | 1983 | 1096 | 0.010 |
Why?
|
Haplorhini | 1 | 1979 | 525 | 0.010 |
Why?
|
Hypermedia | 1 | 1998 | 20 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2005 | 1165 | 0.010 |
Why?
|
Intubation, Gastrointestinal | 1 | 1979 | 166 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 1986 | 3595 | 0.010 |
Why?
|
Femur | 1 | 1984 | 1307 | 0.010 |
Why?
|
Cystitis | 1 | 1978 | 95 | 0.010 |
Why?
|
Peritonitis | 1 | 1979 | 368 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 1984 | 716 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 1984 | 1265 | 0.010 |
Why?
|
Iodine | 1 | 1979 | 288 | 0.010 |
Why?
|
History, 19th Century | 1 | 1979 | 720 | 0.010 |
Why?
|
Database Management Systems | 1 | 1998 | 257 | 0.010 |
Why?
|
Hip Joint | 2 | 1982 | 1014 | 0.010 |
Why?
|
Diagnosis-Related Groups | 1 | 1998 | 449 | 0.010 |
Why?
|
Kidney | 2 | 1994 | 7048 | 0.010 |
Why?
|
Vomiting | 1 | 1979 | 651 | 0.010 |
Why?
|
Databases as Topic | 1 | 1998 | 473 | 0.010 |
Why?
|
Elbow Joint | 1 | 1980 | 359 | 0.010 |
Why?
|
Hematuria | 1 | 1997 | 233 | 0.010 |
Why?
|
Computer Security | 1 | 1998 | 261 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1981 | 1229 | 0.010 |
Why?
|
Intestinal Obstruction | 1 | 1979 | 432 | 0.010 |
Why?
|
Regression Analysis | 1 | 2004 | 6343 | 0.010 |
Why?
|
Occupational Diseases | 1 | 1983 | 1490 | 0.010 |
Why?
|
Infant | 4 | 1986 | 36192 | 0.010 |
Why?
|
Safety | 1 | 1999 | 1150 | 0.010 |
Why?
|
Kidney Cortex | 1 | 1993 | 169 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2007 | 15631 | 0.010 |
Why?
|
Hepatic Veins | 1 | 1993 | 112 | 0.010 |
Why?
|
Chronic Disease | 2 | 1988 | 9318 | 0.010 |
Why?
|
Recurrence | 1 | 1986 | 8465 | 0.010 |
Why?
|
Emergencies | 1 | 1979 | 1217 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1979 | 2329 | 0.010 |
Why?
|
Electronystagmography | 1 | 1992 | 25 | 0.010 |
Why?
|
Cerebellopontine Angle | 1 | 1993 | 53 | 0.010 |
Why?
|
Vocal Cord Paralysis | 1 | 1996 | 272 | 0.010 |
Why?
|
Abdominal Muscles | 1 | 1993 | 169 | 0.010 |
Why?
|
Cost Savings | 1 | 1998 | 913 | 0.010 |
Why?
|
Bile Ducts | 1 | 1993 | 282 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2004 | 3461 | 0.010 |
Why?
|
Bleeding Time | 1 | 1991 | 83 | 0.010 |
Why?
|
Child, Preschool | 4 | 1993 | 42230 | 0.010 |
Why?
|
Hospital Costs | 1 | 1998 | 947 | 0.010 |
Why?
|
Central Nervous System | 1 | 1999 | 1336 | 0.010 |
Why?
|
Temperature | 2 | 1991 | 2226 | 0.010 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1978 | 782 | 0.010 |
Why?
|
Portal Vein | 1 | 1993 | 431 | 0.010 |
Why?
|
Larynx | 1 | 1995 | 492 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2219 | 0.010 |
Why?
|
Suction | 1 | 1991 | 266 | 0.010 |
Why?
|
Patient Admission | 1 | 1998 | 1367 | 0.010 |
Why?
|
Technology, Pharmaceutical | 1 | 1990 | 84 | 0.010 |
Why?
|
Solubility | 1 | 1991 | 1091 | 0.010 |
Why?
|
Acute Disease | 1 | 1980 | 7237 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1995 | 1440 | 0.000 |
Why?
|
Postoperative Period | 1 | 1994 | 1813 | 0.000 |
Why?
|
Urology | 1 | 1994 | 400 | 0.000 |
Why?
|
Citrates | 1 | 1988 | 134 | 0.000 |
Why?
|
Technetium Tc 99m Medronate | 1 | 1988 | 131 | 0.000 |
Why?
|
Citric Acid | 1 | 1988 | 123 | 0.000 |
Why?
|
Temporal Bone | 1 | 1993 | 683 | 0.000 |
Why?
|
Prostate-Specific Antigen | 1 | 1997 | 2469 | 0.000 |
Why?
|
Metrizamide | 1 | 1987 | 17 | 0.000 |
Why?
|
Decision Making | 1 | 1981 | 3929 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1978 | 2091 | 0.000 |
Why?
|
Health Services Accessibility | 1 | 2004 | 5440 | 0.000 |
Why?
|
Pancreas | 1 | 1993 | 1691 | 0.000 |
Why?
|
Emulsions | 1 | 1987 | 152 | 0.000 |
Why?
|
Iopamidol | 1 | 1987 | 186 | 0.000 |
Why?
|
Prognosis | 2 | 1984 | 29625 | 0.000 |
Why?
|
Child | 4 | 1993 | 80153 | 0.000 |
Why?
|
Catheterization | 1 | 1991 | 1428 | 0.000 |
Why?
|
Hemorrhage | 1 | 1978 | 3424 | 0.000 |
Why?
|
Pulmonary Embolism | 1 | 1978 | 2567 | 0.000 |
Why?
|
Fluorine | 1 | 1985 | 83 | 0.000 |
Why?
|
Adenoma | 2 | 1986 | 2160 | 0.000 |
Why?
|
Twins, Conjoined | 1 | 1984 | 41 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1999 | 12341 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 1986 | 9031 | 0.000 |
Why?
|
Length of Stay | 1 | 1998 | 6425 | 0.000 |
Why?
|
Carcinoma | 2 | 1986 | 2330 | 0.000 |
Why?
|
Freeze Drying | 1 | 1984 | 101 | 0.000 |
Why?
|
Carcinoma, Small Cell | 1 | 1986 | 420 | 0.000 |
Why?
|
Risk Assessment | 1 | 2005 | 23995 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2004 | 26125 | 0.000 |
Why?
|
Hormones, Ectopic | 1 | 1982 | 37 | 0.000 |
Why?
|
Pheochromocytoma | 1 | 1985 | 328 | 0.000 |
Why?
|
Follow-Up Studies | 2 | 1998 | 39106 | 0.000 |
Why?
|
Adipose Tissue | 1 | 1993 | 3312 | 0.000 |
Why?
|
Quality of Health Care | 1 | 1997 | 4330 | 0.000 |
Why?
|
Aortography | 1 | 1983 | 421 | 0.000 |
Why?
|
Neoplasm Transplantation | 1 | 1985 | 2016 | 0.000 |
Why?
|
Colonic Diseases | 1 | 1982 | 201 | 0.000 |
Why?
|
Age Factors | 1 | 1997 | 18395 | 0.000 |
Why?
|
Adrenocorticotropic Hormone | 1 | 1982 | 618 | 0.000 |
Why?
|
Cellulitis | 1 | 1982 | 209 | 0.000 |
Why?
|
Vena Cava, Inferior | 1 | 1983 | 458 | 0.000 |
Why?
|
Aspirin | 1 | 1991 | 3133 | 0.000 |
Why?
|
Fluorocarbons | 1 | 1985 | 492 | 0.000 |
Why?
|
Particle Size | 1 | 1984 | 1648 | 0.000 |
Why?
|
Cadaver | 1 | 1984 | 1358 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1979 | 26198 | 0.000 |
Why?
|
Aorta, Abdominal | 1 | 1982 | 625 | 0.000 |
Why?
|
Skull | 1 | 1984 | 818 | 0.000 |
Why?
|
Organ Specificity | 1 | 1984 | 1967 | 0.000 |
Why?
|
Posture | 1 | 1983 | 957 | 0.000 |
Why?
|
Anti-Glomerular Basement Membrane Disease | 1 | 1978 | 41 | 0.000 |
Why?
|
Arthritis | 1 | 1984 | 680 | 0.000 |
Why?
|
Risk Factors | 1 | 2005 | 74206 | 0.000 |
Why?
|
Chelating Agents | 1 | 1979 | 387 | 0.000 |
Why?
|
Muscular Diseases | 1 | 1982 | 553 | 0.000 |
Why?
|
Basement Membrane | 1 | 1978 | 349 | 0.000 |
Why?
|
Leg | 1 | 1982 | 1088 | 0.000 |
Why?
|
Uremia | 1 | 1978 | 201 | 0.000 |
Why?
|
Blood Vessel Prosthesis | 1 | 1982 | 952 | 0.000 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 1992 | 4016 | 0.000 |
Why?
|
Glomerulonephritis | 1 | 1978 | 331 | 0.000 |
Why?
|
Kidney Glomerulus | 1 | 1978 | 568 | 0.000 |
Why?
|
Pregnancy | 3 | 1984 | 29874 | 0.000 |
Why?
|
Gestational Age | 1 | 1984 | 3577 | 0.000 |
Why?
|
Bacterial Infections | 1 | 1982 | 1390 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1984 | 4915 | 0.000 |
Why?
|
Syndrome | 1 | 1978 | 3267 | 0.000 |
Why?
|
Antibodies | 1 | 1978 | 2418 | 0.000 |
Why?
|
Crohn Disease | 1 | 1982 | 2279 | 0.000 |
Why?
|
Ovarian Neoplasms | 1 | 1986 | 4876 | 0.000 |
Why?
|
Pancreatic Neoplasms | 1 | 1986 | 5368 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1986 | 9280 | 0.000 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1978 | 2155 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1984 | 18252 | 0.000 |
Why?
|
Brain | 1 | 1986 | 27112 | 0.000 |
Why?
|
Mice | 1 | 1981 | 81525 | 0.000 |
Why?
|